Evidence map›Paper›PMID 28628094›Full record

ArticleNature chemical biology2017

A water-soluble DsbB variant that catalyzes disulfide-bond formation in vivo.

Dario Mizrachi, Michael-Paul Robinson, Guoping Ren, Na Ke, Mehmet Berkmen, Matthew P DeLisa

RetractedAbstract readRetracted Publication
In one paragraph

Article in Nature chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dario MizrachiSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York, USA.
Michael-Paul RobinsonSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York, USA.
Guoping RenNew England Biolabs, Ipswich, Massachusetts, USA.
Na KeNew England Biolabs, Ipswich, Massachusetts, USA.
Mehmet BerkmenNew England Biolabs, Ipswich, Massachusetts, USA.
Matthew P DeLisaSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York, USA.ORCID http://orcid.org/0000-0003-3226-1566
Cornell University · USNew England Biolabs (United States) · US

Funding

Overall (pp. 40-62)P41GM103485 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2012 to 2018
$15.5M
Discovery of antibodies that bind G protein-coupled receptorsR21DA031409 · NIDA · CORNELL UNIVERSITY · PI DELISA, MATTHEW P · 2011 to 2012
$437k
NIDA NIH HHS R21 DA031409NIGMS NIH HHS P41 GM103485
6 · The paper itself

Abstract

Escherichia coli DsbB is a transmembrane enzyme that catalyzes the reoxidation of the periplasmic oxidase DsbA by ubiquinone. Here, we sought to convert membrane-bound DsbB into a water-soluble biocatalyst by leveraging a previously described method for in vivo solubilization of integral membrane proteins (IMPs). When solubilized DsbB variants were coexpressed with an export-defective copy of DsbA in the cytoplasm of wild-type E. coli cells, artificial oxidation pathways were created that efficiently catalyzed de novo disulfide-bond formation in a range of substrate proteins, in a manner dependent on both DsbA and quinone. Hence, DsbB solubilization was achieved with preservation of both catalytic activity and substrate specificity. Moreover, given the generality of the solubilization technique, the results presented here should pave the way to unlocking the biocatalytic potential of other membrane-bound enzymes whose utility has been limited by poor stability of IMPs outside of their native lipid-bilayer context.

Indexed as

Bacterial ProteinsCatalysisDisulfidesGenetic VariationMembrane ProteinsModels, BiologicalProtein EngineeringProtein FoldingSolubilityWaterBacterial ProteinsDisulfidesDsbB protein, BacteriaMembrane ProteinsWater

Identifiers

PMID28628094
PMCPMC5562517
OpenAlexW2723681476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.